Precision medicine in advanced NENs: Molecular profiling and target actionability real world data

被引：0
|
作者：
Farinea, G. [1 ]
Anton-Pascual, B. [2 ]
Catoya, J. L. [2 ]
Modrego, A. [2 ]
La Salvia, A. [3 ]
Lens-Pardo, A. [4 ]
Carretero-Puche, C. [4 ]
Rubio-Cuesta, B. [4 ]
Lamas-Paz, A. [4 ]
Soldevilla, B. [4 ]
Garcia-Carbonero, R. [2 ]
机构：
[1] AOU Osped San Luigi, Turin, Italy
[2] Hosp 12 Octubre, Madrid, Spain
[3] Natl Inst Hlth ISS, Natl Ctr Drug Res & Evaluat, Rome, Italy
[4] Hosp 12 Octubre, Inst Invest Sanitaria, CNIO, Madrid, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2024年 / 36卷
关键词：
genomic profiling; escat; nen; precision medicine;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F04
引用
收藏
页码：153 / 153
页数：1
相关论文
共 50 条
  • [41] Precision medicine: Preliminary results from the initiative for molecular profiling and advanced cancer therapy 2 (IMPACT 2) study
    Tsimberidou, A. M.
    Hong, D. S.
    Fu, S.
    Karp, D.
    Piha-Paul, S. A.
    Kies, M.
    Ravi, V.
    Subbiah, V.
    Patel, S.
    Tu, S. -M.
    Janku, F.
    Heymach, J.
    Johnson, A.
    Zhao, L.
    Zhang, J.
    Berry, D. A.
    Vining, D.
    Futreal, A.
    Miller, V. A.
    Meric-Bernstam, F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] Stratification of patients by tumor type using molecular profiling in real-world data.
    Antonopoulos, Alyssa
    Eldridge, Elizabeth
    Managadze, George
    Stupka, Elia
    Lakhani, Hakim
    Mahmood, Sadiqa
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Sequential Everolimus and Sunitinib treatment in progressive, advanced, pancreatic NENs: Real-world data from the Belgian Group of Digestive Oncology DNET & NETwerk
    Islam, O.
    van de Vyver, G.
    Verslype, C.
    Borbath, I
    Decaestecker, J.
    Botelberge, T.
    Geboes, K.
    Cuyle, P. J.
    Clausse, M.
    Lybaert, W.
    Peeters, M.
    Vandamme, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 238 - 238
  • [44] Real-world data in the molecular erafinding the reality in the real world
    Dickson, D. J.
    Pfeifer, J. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) : 186 - 197
  • [45] World Molecular Imaging Congress 2015: Precision Medicine Visualized
    H. Charles Manning
    Molecular Imaging and Biology, 2015, 17 : 295 - 296
  • [46] Advances in AIT: Precision medicine, biomarkers and real-world evidence
    Ayazpoor, Ute
    ALLERGO JOURNAL, 2024, 33 (05) : 39 - 39
  • [47] Precision Medicine: Generating Real-World Evidence for Companion Diagnostics
    Horn, Elizabeth J.
    Terry, Sharon F.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (02) : 75 - 76
  • [48] Real-world evidence of precision medicine for biliary tract cancer
    Hayashi, Hideyuki
    Tanishima, Shigeki
    Fujikura, Tomoka
    Nakamura, Kohei
    Ishikawa, Marin
    Kato, Yasutaka
    Kawano, Ryutaro
    Hirata, Kenro
    Hamamoto, Yasuo
    Nishihara, Hiroshi
    ANNALS OF ONCOLOGY, 2023, 34 : S1417 - S1417
  • [49] A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
    Mateo, J.
    Chakravarty, D.
    Dienstmann, R.
    Jezdic, S.
    Gonzalez-Perez, A.
    Lopez-Bigas, N.
    Ng, C. K. Y.
    Bedard, P. L.
    Tortora, G.
    Douillard, J. -Y.
    Van Allen, E. M.
    Schultz, N.
    Swanton, C.
    Andre, F.
    Pusztai, L.
    ANNALS OF ONCOLOGY, 2018, 29 (09) : 1895 - 1902
  • [50] Precision medicine using molecular-target drugs in psoriatic arthritis
    Miyagawa, Ippei
    Tanaka, Yoshiya
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2025, 17
12345